A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis

@article{Jameson1994ARD,
  title={A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis},
  author={B. Jameson and J. M. McDonnell and J. Marini and R. Korngold},
  journal={Nature},
  year={1994},
  volume={368},
  pages={744-746}
}
EXPERIMENTAL allergic encephalomyelitis (EAE) is an acute inflammatory autoimmune disease of the central nervous system that can be elicited in rodents and is the major animal model for the study of multiple sclerosis (MS)1,2. The pathogenesis of both EAE and MS directly involves the CD4+ helper T-cell subset3–5. Anti-CD4 monoclonal antibodies inhibit the development of EAE in rodents6–9, and are currently being used in human clinical trials for MS. We report here that similar therapeutic… Expand
127 Citations
Suppression of Experimental Autoimmune Encephalomyelitis Using Peptide Mimics of CD281
  • 57
  • PDF
Experimental immunotherapies for multiple sclerosis
  • 11
A synthetic mimetic of CD4 is able to suppress disease in a rodent model of immune colitis
  • 47
CNS Dendritic Cells in Inflammation and Disease
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Immunological aspects of demyelinating diseases.
  • 1,058
T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice
  • 99
MS: a CNS and systemic autoimmune disease.
  • 254
...
1
2
3
...